Valuation: LivaNova PLC

Market Cap 5.21B 4.74B 4.39B 3.97B 7.45B 486B 7.8B 53.09B 21.06B 263B 19.54B 19.13B 833B P/E 2026 *
28.1x
P/E 2027 * 29.1x
Enterprise Value 5.28B 4.81B 4.46B 4.03B 7.56B 493B 7.91B 53.86B 21.36B 267B 19.82B 19.4B 845B EV / Sales 2026 *
3.45x
EV / Sales 2027 * 3.13x
Free-Float
97.7%
Yield 2026 *
-
Yield 2027 * -
1 day-2.52%
1 week+2.20%
Current month+16.73%
1 month+17.97%
3 months+14.03%
6 months+26.42%
Current year+49.82%
1 week 88.63
Extreme 88.63
95.4
1 month 78
Extreme 78.005
99.38
Current year 56.44
Extreme 56.44
99.38
1 year 53.36
Extreme 53.365
99.38
3 years 32.48
Extreme 32.48
99.38
5 years 32.48
Extreme 32.48
99.38
10 years 32.48
Extreme 32.48
131.54
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2024
Director of Finance/CFO 56 31/10/2020
Investor Relations Contact - 01/08/2022
Director TitleAgeSince
Director/Board Member 69 19/10/2015
Chairman 74 09/06/2021
Director/Board Member 62 18/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
15/9/26 Free

General Counsel

6,291 0.0114%
10/9/26 Sell

Director

-3,500 0.0064%
4/9/26 Sell

Director

-2,300 0.0042%
Change 5-day change 1-year change 3-year change Capi.($)
-2.54%+2.20%+70.99%+96.72% 5.21B
-0.26%-2.97%-17.51%+2.83% 181B
-0.06%-0.60%+0.04%+33.56% 123B
-1.56%+0.11%-14.14%+8.10% 121B
-2.21%-3.15%-43.22%-1.44% 91.11B
-1.82%-2.42%-5.49%+74.00% 66.47B
-1.43%-1.25%+11.40%-8.84% 58.86B
-1.17%-1.40%-1.27%+45.53% 55.03B
+0.38%-1.22%+2.17%+39.18% 48.88B
+1.60%+6.46%+5.64%+1.34% 35.5B
Average -0.83%+0.13%+0.86%+29.10% 79B
Weighted average by Cap. -0.78%-1.09%-10.05%+18.91%

Financials

2026 *2027 *
Net sales 1.53B 1.39B 1.29B 1.17B 2.19B 143B 2.29B 15.61B 6.19B 77.27B 5.74B 5.62B 245B 1.64B 1.49B 1.38B 1.25B 2.35B 153B 2.46B 16.71B 6.63B 82.72B 6.15B 6.02B 262B
Net income 188M 171M 158M 143M 268M 17.51B 281M 1.91B 758M 9.46B 703M 689M 29.97B 165M 150M 139M 126M 235M 15.37B 246M 1.68B 665M 8.3B 617M 604M 26.3B
Net Debt 75M 68.33M 63.26M 57.22M 107M 7B 112M 765M 303M 3.79B 281M 275M 11.99B -85M -77.44M -71.69M -64.85M -122M -7.94B -127M -867M -344M -4.29B -319M -312M -13.59B
Projected Income Statement - Annual - LivaNova PLC
Logo LivaNova PLC
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Employees
3,300
Date Price Change Volume
20/11/26 USD 92.18 -2.49% 330,808
18/11/26 USD 94.54 +2.85% 1,321,142
17/11/26 USD 91.92 -0.56% 573,618
16/11/26 USD 92.44 +1.23% 805,676
13/11/26 USD 91.32 +1.24% 742,278
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - LivaNova PLC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
94.54USD
Average target price
105.09USD
Spread / Average Target
+11.16%
  1. Stock Market
  2. Stocks
  3. LIVN Stock